The Growth Channel

The latest innovations in market strategy and share competition

Check your strategic vision and focus on ophthalmology

By Tali Warburg July 29, 2015

In the game of ambulatory strategy, have you zeroed in on ophthalmology? Keep your eyes open and evaluate this high-growth service line as a component of your ambulatory strategy.

According to The Advisory Board Company's outpatient market projections, ophthalmology is the fourth fastest growing service line, with national outpatient volumes projected to grow 22% by 2019. More specifically, glaucoma procedures are projected to experience the fifth fastest growth of any subservice line—64% by 2019.

Read more »

Four lessons to help you prepare for mandatory bundled payment

By Sebastian Beckmann July 28, 2015

Bundled payment models have long held promise as a mechanism for achieving savings for joint replacements—but until now, participation in those models has been voluntary. Last week, we told you about the newly-proposed Comprehensive Care for Joint Replacement (CCJR) program, which would make bundled payment for joint replacements mandatory for hospitals in 75 regions. Although the program is still a proposal, hospitals across the country should begin assessing their ability to improve the value of joint replacements and effectively coordinate care with other providers.

To help you prepare, this week we’re bringing you four lessons learned by the hospitals, health systems, and physician groups participating in Model 2 of CMS' Bundled Payments for Care Improvement (BPCI). Because the CCJR program is similar to BPCI’s Model 2, the experiences and strategies used by BPCI participants can help guide your preparations.

Read more »

Pediatric systems are seeking new partners. Who makes the cut?

Alan Lassiter MD, MBA July 23, 2015

The other day, I ran across a job posting that epitomized how much the strategic landscape in pediatric acute care has changed. According to the LinkedIn post, a certain top-tier pediatric system in the Northeast is looking for an executive to design and execute “innovative partnership models.”

Why was this job description so telling? Because children’s hospitals around the country are realizing that to succeed in the consumer-driven, value-based health care market, they will need partners—and maybe not the same partners that they’ve had in the past.

Read more »

6 takeaways from CMS's proposed mandatory joint replacement bundle

By Sebastian Beckmann July 20, 2015

Late last week, CMS proposed the Comprehensive Care for Joint Replacement Model (CCJR), a new bundled payment model for lower extremity joint replacement. CCJR resembles Model 2 of Bundled Payments for Care Improvement (BPCI), CMS' pilot program for bundled payment. But unlike BPCI, any hospital in 75 Metropolitan Statistical Areas (MSA's) would be required to participate. While the proposed five-year CCJR program would not apply to providers outside those regions, its geographic scope and mandatory participation constitute a tremendous statement from CMS, which has pledged to shift 50% of Medicare payments to value-based models by 2018. Overall, CCJR foreshadows a broader move to integrated care for hospitals everywhere. 

CMS' choice of joint replacement to introduce mandatory bundled payments is not surprising. Joint replacements are expensive, high-volume procedures with significant cost variation between hospitals and strong expected growth. Lower extremity joint replacement was also the most popular procedure chosen under BPCI, with a number of participants able to improve cost performance while maintaining quality outcomes.

Read more »

Four keys to fast track your market growth strategy

July 6, 2015

Recently, the Crimson Market Advantage team had the privilege of hosting a Market Strategy Intensive for health system executives at our headquarters in Washington, D.C.

The agenda included insightful, thought-provoking remarks from both Advisory Board experts and Crimson Market Advantage members. In case you missed it, here are four key themes from the meeting.  

Read more »

The strategy that has already helped fix oncology

By Matt Morrill July 1, 2015

Though it's a couple years old by now, Michael Porter’s and Thomas Lee’s article, "The Strategy That Will Fix Health Care," is still very relevant (and controversial, depending on whom you ask). In it, Porter and Lee describe a "fundamentally new strategy" for health care focused on creation of "integrated practice units" (IPUs), which are multidisciplinary teams of co-located clinicians focused around treating a specific disease, among other initiatives.

To some specialties, this probably represents a huge shift in both practice patterns and ways of thinking. But this innovative strategy is already well-known and utilized within oncology through the development of tumor site programs.

Read more »

Eight steps to ramping up a new specialty practice

Sarah Aronson Rosen June 17, 2015

Bringing a new physician into your network is one thing, getting them busy is another. Even the most promising acquisitions can be a money loser in the short-term as the investment in the new practice may outweigh the incoming revenue. Often organizations bringing on new practices will rely on the physicians themselves to fill their schedules—but a little well-planned physician marketing can serve as a capable accelerator.

We recently worked with an organization located in the Midwest to create a business development plan for a new neurologist and ENT group to introduce this practice to other physicians and and the community. Ramping up a new practice isn’t any different from a typical best practice approach to physician outreach. Read on for our tips for your organization.

Read more »

From controversy to engagement: Talking about laparoscopic power morcellation with physicians and patients

By Catherine Parkhurst June 11, 2015

News of a minimally invasive surgical technique that can spread cancer could jeopardize your relationships with physicians and patients.

Recent studies show that laparoscopic power morcellation (a minimally invasive device) could spread unsuspected uterine cancer—putting as many as 1-in-325 women receiving a hysterectomy or myomectomy with this device at risk.

Read more »

  • Manage your events
  • View your saved items
  • Manage your subscriptions
  • Update personal information
  • Invite a colleague